Adverse drug reactions in hospitalized children in Fortaleza, Brazil

Pharmacoepidemiology and Drug Safety

Volumn 15, Issue 9, 2006, Pages 635-640

  Barbosa dos Santos, Djanilson ^a,b   Luna Coelho, Helena Lutéscia ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b NONE

Author keywords

Adverse drug reactions; Children; Cohort studies; Hospitalized children; Pediatric patients

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DIPYRONE; HORMONE; HYDROCORTISONE; OXACILLIN; VANCOMYCIN;

ADOLESCENT; ARTICLE; BRAZIL; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILD CARE; CHILD HOSPITALIZATION; COHORT ANALYSIS; CONTROLLED STUDY; CUSHING SYNDROME; DIARRHEA; DISEASE SEVERITY; DROWSINESS; DRUG ERUPTION; DRUG EXPOSURE; DRUG FEVER; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; ENDOCRINE DISEASE; ERYTHEMA; ERYTHEMA MULTIFORME; FEMALE; GASTROINTESTINAL DISEASE; GENDER; HOSPITALIZED CHILD; HUMAN; INCIDENCE; INFANT; LIVER FAILURE; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTIVARIATE ANALYSIS; NAUSEA AND VOMITING; PEDIATRIC HOSPITAL; PHARMACEUTICAL CARE; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RISK FACTOR; SKIN APPENDAGE DISEASE; SKIN DISEASE; SYSTEMIC THERAPY; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; BRAZIL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INCIDENCE; INFANT; MALE; PHARMACEUTICAL PREPARATIONS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33748771960     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1187     Document Type: Article

References (22)

1. Impicciatore P, Choonara I, Clarkson A, et al. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analisis of prospective studies. Br J Clin Pharmacol 2001; 52: 77-83.
2. Weiss J, Krebs S, Hoffmann C, et al. Survey of adverse drug reactions on a pediatric ward: a strategy for early and detailed detection. Pediatrics 2002; 110: 254-258.
3. Buajordet I, Wesenberg F, Brors O, et al. Adverse drug events in children during hospitalization and after discharge in a Norwegian University Hospital. Acta Paediatric 2002; 91: 88-94.
4. Clarkson A, Choonara I. Surveillance for fatal suspected adverse drug reactions in the UK. Arch Dis Child 2002; 87: 462-467.
5. Gill AM, Leach HJ, Hughes J, et al. Adverse drug reactions in a paediatric intensive care unit. Acta Paediatrica 1995; 84: 438-441.
6. Turner S, Nunn AJ, Fielding K, et al. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paedatrica 1999; 88: 965-968.
7. Clarkson A, Ingleby E, Choonara I, et al. A novel scheme for the reporting of adverse drug reactions. Arch Dis Child 2001; 84: 337-339.
8. Bonati M, Impicciatore P, Pandolfini C. The registry of clinical trials in children must b set up. Br Med J 2000; 320: 1339-1340.
9. Conroy S, Choonara I, Impicciatore P. Survey of unlicensed and off label drug use in paediatric wards in European countries. Br Med J 2000; 320: 79-82.
10. Martinez-Mir I, Garcia-Lopez M, Palop V, et al. A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 1999; 47: 681-688.
11. Vazques de la Villa A, Luna del Castillo JD, Galdo-Munoz G, et al. Reacciones adversas causadas por medicamentos en pediatria. An Esp Pediatr 1989; 31: 49-53.
12. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205.
13. WHO. Collaborating Center for International Drug Monitoring of Adverse Reaction Terminology. WHO: Uppsala, 1984.
14. Ministry of Health. National Retionship of Essential Medicines: RENAME-2000. Brasília: General Office of politics of health, Ministry of Health; 2000.
15. WHO. Collaborating Center for International Drug Monitoring. WHO: Geneva, 1984.
16. Coelho HL, Arrais PSD, Gomes AP. Sistema de Farmacovigilncia do Ceará: um ano de experiência. Cadernos de Saúde Pública, 1999; 15: 631-640.
17. WHO. Collaborating Center for Drug Statistics Methodology Guidelines for ATC Classification and DDD Assignment. WHO: Geneva, 1996.
18. Gonzalez MG, Caroca CM, Paris E. Adverse drug reactions (ADRs) in hospitalized pediatric patients. A prospective study. Int J Clin Pharmacol Ther 1998; 36: 530-533.
19. Mitchell AA, Goldman P, Shapiro S, et al. Drug utilization and reported adverse reactions in hospitalized children. Am J Epidemiol 1979; 110: 196-204.
20. Whyte J, Greenan E. Drug usage and adverse drug reactions in paediatric patients. Acta Paediatric Scand 1977; 66: 767-775.
21. Jonville-Béra AP, Giraudeau B, Blanc P, et al. Frequency of adverse drug reactions in children: a prospective study. Br J Clin Pharmacol 2002; 53: 207.
22. Choonara IA, Harris F. Adverse reactions in medical inpatients. Arch Dis Child 1984; 59: 578-580.